SCHEMBL4745860

SCHEMBL4745860

Cc1ccc2c(c1)c(-c1cccc3ccccc13)cc1c3ccc(C)c4c3c(cc21)-c1ncccc1-4

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.35
TOP2A P11388 1/20 0.35
MAOB P27338 1/20 0.35
TGFBR1 P36897 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2A6 P11509 1/20 0.34
CCR1 P32246 1/20 0.34
CCR8 P51685 1/20 0.34
BCHE P06276 1/20 0.34
KDR P35968 2/20 0.34
DHFR P00374 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RIPK2 O43353 1/20 0.32
PRKD3 O94806 1/20 0.32
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745959 0.95 CYP1A2 (0.35) MAOATOP2AMAOBTGFBR1CYP1A2
SCHEMBL4745945 0.94 HPRT1 (0.37) MAOATOP2ACYP1A2CYP2A6CCR1
SCHEMBL4746394 0.94 MEN1 (0.32) TOP2ACYP1A2CCR1CCR8BCHE
SCHEMBL4746409 0.93 PDK2 (0.33) TOP2ACYP1A2CCR1CCR8BCHE
SCHEMBL4745849 0.92 CCR1 (0.35) MAOATOP2ACYP1A2CCR1CCR8
SCHEMBL4746272 0.91 MAPT (0.32) TOP2ACCR1CCR8BCHEKDM4E
SCHEMBL4746180 0.90 TOP2A (0.37) MAOATOP2ACYP1A2CYP2A6CCR1
SCHEMBL4745880 0.90 MAPT (0.34) TOP2ABCHEALDH1A1KDM4EMAPT
SCHEMBL4745982 0.90 ALDH1A1 (0.34) TOP2ABCHEALDH1A1KDM4EGAA
SCHEMBL4746466 0.90 TOP2A (0.32) TOP2ACYP1A2CCR1CCR8BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 MAOA 460/4885TOP2A 1041/4885MAOB 418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.